Mobile Psychosocial Interventions for MMT Clients
MobileMMT
Providing Psychosocial Interventions to Substance Abusers Via Mobile Technology
2 other identifiers
interventional
219
1 country
1
Brief Summary
This study will develop and evaluate the preliminary efficacy and cost-effectiveness of a mobile phone-delivered psychosocial intervention for opioid-dependent adults (N=219) in methadone maintenance treatment (MMT). A three-arm, randomized clinical trial will evaluate the relative efficacy of: (1) standard MMT; (2) standard MMT plus the mobile intervention; and (3) a mobile-based control condition on the primary outcomes of treatment retention and opioid use (assessed via urine toxicology). If results are promising, this novel therapeutic tool may have a tremendous impact on improving access to and effectiveness of substance abuse treatment in a variety of other populations (and could also be adapted for an array of other behavioral health applications), while significantly limiting costs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 29, 2012
CompletedFirst Posted
Study publicly available on registry
July 4, 2012
CompletedStudy Start
First participant enrolled
July 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2018
CompletedSeptember 14, 2017
September 1, 2017
3.3 years
June 29, 2012
September 13, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
treatment retention
participants' retention in methadone maintenance treatment (MMT)
6 months
opioid use
participants' illicit use of opioids, as measured by urine toxicology and self-report (self-report data collected via the timeline follow-back calendar assessment \[TLFB\])
6 months
Secondary Outcomes (6)
other substance use
6 months
coping skills
6 months
readiness to change drug use
6 months
heroin/opioid craving
6 months
HIV risk behavior
6 months
- +1 more secondary outcomes
Study Arms (3)
standard treatment
OTHERthe standard drug counseling offered to patients in methadone maintenance treatment at the study site
Mobile Therapeutic System (MTS)
EXPERIMENTALThe Mobile Therapeutic System (MTS) is a novel, interactive, mobile phone-delivered psychosocial intervention designed to promote skills acquisition and reduce drug use among adults in methadone maintenance treatment
mobile control
ACTIVE COMPARATORa mobile phone-based application that directs participants to the NIDA website's home page
Interventions
the standard drug counseling offered to patients at the study site's methadone maintenance program
a novel, interactive, mobile phone-delivered psychosocial intervention designed to promote skills acquisition and reduce drug use among adults in methadone maintenance treatment
a mobile phone-based application that directs participants to the NIDA website's homepage
Eligibility Criteria
You may qualify if:
- client enrolled in the study site's methadone maintenance program
- within the first month of initiating methadone maintenance treatment
- years of age or older
- sufficient English-language ability to participate in informed consent process, complete study assessments and understand the text in mobile phone- delivered interventions
You may not qualify if:
- entering treatment at the study site with the intention of receiving a methadone-assisted withdrawal only
- evidence of an active psychiatric disorder requiring immediate intervention (e.g., suicidality, psychosis)
- evidence of significant mental illness that may preclude participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bridge Plaza Treatment and Rehabilitation Clinic
Long Island City, New York, 11101, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michelle Acosta, Ph.D.
National Development and Research Institutes (NDRI)
- PRINCIPAL INVESTIGATOR
Lisa A. Marsch, Ph.D.
Dartmouth College
- STUDY DIRECTOR
Honoria Guarino, Ph.D.
National Development and Research Institutes (NDRI)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 29, 2012
First Posted
July 4, 2012
Study Start
July 1, 2013
Primary Completion
November 1, 2016
Study Completion
September 1, 2018
Last Updated
September 14, 2017
Record last verified: 2017-09